After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Want to make money from home? Discover various ways to earn money from home that fit your lifestyle and preferences.
12,971 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
A surge in investor interest centers on SPCX as SpaceX expands its orbit into launches, satellite networks, and AI ve...
Two global asset managers, two different paths to growth. This analysis pits BlackRock and Invesco against each other...
Investors can access retirement funds before 59½ without the 10% penalty if they follow the Substantially Equal Perio...
A $46 billion smart wall project along the U.S.-Mexico border accelerates, blending a tall fence with AI-powered sens...
Michael Burry has added a Micron short, expanding a wager that AI-driven chip stocks may soon pull back. The move com...
XRP trades near $1.05 as on-chain MVRV metrics flash a rare setup. A breakout above stubborn resistance could unlock ...
Legendary investor Michael Burry has taken a direct short against Micron Technology, challenging the view that AI-dri...
As AI reshapes markets, critics say consumer data funds the surge while a handful of platforms claim the profits. Thi...
A warning from SK Hynix could ripple through the NAND market and Sandisk stock. This guide breaks down what the hynix...
SpaceX has joined the Nasdaq 100, triggering a wave of expected passive buying estimated at $27 billion as lockups un...
A retiring CFO faces a pivotal decision: take a lump-sum payout from a long‑standing nonqualified deferred compensati...